VisANT 3.5: multi-scale network visualization, analysis and inference based on the gene ontology Z Hu, JH Hung, Y Wang, YC Chang, CL Huang, M Huyck, C DeLisi Nucleic acids research 37 (suppl_2), W115-W121, 2009 | 246 | 2009 |
VisANT 4.0: Integrative network platform to connect genes, drugs, diseases and therapies Z Hu, YC Chang, Y Wang, CL Huang, Y Liu, F Tian, B Granger, C DeLisi Nucleic acids research 41 (W1), W225-W231, 2013 | 152 | 2013 |
H3B-6527 is a potent and selective inhibitor of FGFR4 in FGF19-driven hepatocellular carcinoma JJ Joshi, H Coffey, E Corcoran, J Tsai, CL Huang, K Ichikawa, S Prajapati, ... Cancer research 77 (24), 6999-7013, 2017 | 129 | 2017 |
Using functional signatures to identify repositioned drugs for breast, myelogenous leukemia and prostate cancer D Shigemizu, Z Hu, JH Hung, CL Huang, Y Wang, C DeLisi PLoS computational biology 8 (2), e1002347, 2012 | 72 | 2012 |
Sensitivity to splicing modulation of BCL2 family genes defines cancer therapeutic strategies for splicing modulators D Aird, T Teng, CL Huang, E Pazolli, D Banka, K Cheung-Ong, C Eifert, ... Nature communications 10 (1), 137, 2019 | 69 | 2019 |
TATA binding proteins can recognize nontraditional DNA sequences S Ahn, CL Huang, E Ozkumur, X Zhang, J Chinnala, A Yalcin, ... Biophysical journal 103 (7), 1510-1517, 2012 | 19 | 2012 |
Correlation set analysis: detecting active regulators in disease populations using prior causal knowledge CL Huang, J Lamb, L Chindelevitch, J Kostrowicki, J Guinney, C DeLisi, ... Bmc Bioinformatics 13, 1-15, 2012 | 10 | 2012 |
Combined inhibition of FGFR4 and VEGFR signaling enhances efficacy in FGF19 driven hepatocellular carcinoma X Zhao, JJ Joshi, D Aird, C Karr, K Yu, C Huang, F Colombo, ... American Journal of Cancer Research 12 (6), 2733, 2022 | | 2022 |
Sensitivity to splicing modulation of BCL2 family genes reveals cancer therapeutic strategies for splicing modulators D Aird, T Teng, CL Huang, E Pazolli, D Banka, K Cheung-Ong, C Eifert, ... Cancer Research 79 (13_Supplement), 281-281, 2019 | | 2019 |
A module based approach for identifying driver genes and expanding pathways from integrated biological networks CL Huang Boston University, 2014 | | 2014 |
NF-κB Activation in Breast Cancer Occurs Via Different Mechanisms in Triple Negative and HER2+ Tumors with Lymphocytic Infiltrate. V Tadigotla, G Alexe, N Sethi, E Bilal, C Huang, S Monti, P Tamayo, ... Cancer Research 69 (24_Supplement), 1164-1164, 2009 | | 2009 |